READ FOR EXISTING SHAREHOLDERS ONLY PLEASE DYOR

it's main product price is $299

last quarter revenue 600K, means roughly it sells to 2K customers

This looks like a lot of room to grow for me.

The product is a new alternative in skincare industry, EBITDA looks awful but this is understandable since there's a cost of R&D and marketing.

So the point is this, IF the product can penetrate wider population, considering the growing aging population which needs cure for saggy skin, in that case IF the product can fit perfectly, I think the chance for the company to go bust is low and perhaps it will be acquired by bigger company, the negative cashflow is within the range of $4M is really nothing for big bros.

looking at valuation I think PS should at least be 1, if the revenue keeps growing it should be 4

so the current price 0.019 is about 60% - 70% discount